Key result
MyBPC3 gene mutations were found in 15% of Chinese patients with hypertrophic cardiomyopathy and were associated with significantly higher diastolic dyssynchrony index compared to healthy controls.
Why the study?
Do MyBPC3 gene mutations alter echocardiographic parameters of regional and global diastolic function in Chinese patients with and without left ventricular hypertrophy?
Cross-Sectional (n=71)
No
Do MyBPC3 gene mutations alter echocardiographic parameters of regional and global diastolic function in Chinese patients with and without left ventricular hypertrophy?
MyBPC3 gene mutations in Chinese HCM patients are associated with early regional left ventricular hypertrophic remodeling that precedes global hypertrophy and myocardial diastolic dysfunction.
Answers are grounded in this paper and cite their sources.
MyBPC3 mutations may flag early diastolic dysfunction in HCM; leaves open prospective validation before genotype-guided monitoring.
Hypertrophic cardiomyopathy (HCM) is a common autosomal dominant cardiac disease, affecting 1 in 500 people. Myosin‑binding protein C3 (MyBPC3) gene mutations are the most common genetic cause of HCM. However, the prevalence of the MyBPC3 gene mutation in Chinese patients with HCM, and their echocardiographic characteristics, remain unknown. In the present study, 48 Chinese patients with HCM were sequenced to identify the MyBPC3 gene and were characterized by their clinical features using 2‑dimensional echocardiography and real‑time 3‑dimensional echocardiography. Nine MyBPC3 mutations were identified in seven unrelated patients out of 48 cases, which accounts for a 15% prevalence of MyBPC3 mutations in Chinese patients with HCM. Family members of the seven patients were further tested and divided into the following two groups based on HCM phenotype and MyBPC3 mutations: Positive genotype with left ventricular (LV) hypertrophy (LVH) (G+/LVH+, n=18); and positive genotype without LVH (G+/LVH‑, n=23). These groups were compared with matched normal control subjects (n=30). G+/LVH+ patients showed significantly lower septal and lateral Tissue Doppler imaging (TDI)‑derived systolic, early and late diastolic mitral annular velocities compared with the controls. In addition, diastolic dyssynchrony index (DDI) was markedly higher in the G+/LVH+ subjects. However, only septal Ea was significantly lower in G+/LVH‑ subjects in comparison with controls, with no significant difference in lateral Sa, Ea and Aa, and DDI. In conclusion, the patients in the present study demonstrated a 15% prevalence of MyBPC3 gene mutations in the Chinese HCM population. MyBPC3 gene mutations may cause regional LV hypertrophic remodeling first and further proceed to global hypertrophic remodeling and myocardial diastolic dysfunction.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2017) conducted a cross-sectional in Hypertrophic cardiomyopathy (HCM) (n=71). MyBPC3 gene mutation (G+/LVH+) vs. Healthy age- and gender-matched controls was evaluated on Diastolic dyssynchrony index (DDI) (p=<0.001). MyBPC3 gene mutations were found in 15% of Chinese patients with hypertrophic cardiomyopathy and were associated with significantly higher diastolic dyssynchrony index compared to healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: